Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance

Biomedicine and Pharmacotherapy

Volumn 95, Issue , 2017, Pages 1535-1548

  Salehipour, Zohre ^a   Haghmorad, Dariush ^b   Sankian, Mojtaba ^a   Rastin, Maryam ^a   Nosratabadi, Reza ^c   Soltan Dallal, Mohammad Mehdi ^d   Tabasi, Nafiseh ^a   Khazaee, Mahdieh ^a   Nasiraii, Leila Roozbeh ^e   Mahmoudi, Mahmoud ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SEMNAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

CNS; Experimental autoimmune encephalomyelitis (EAE); Immunotherapy; Multiple sclerosis; Probiotic; Regulatory T (Treg) cell

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 4; PROBIOTIC AGENT; RNA; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSFORMING GROWTH FACTOR BETA; AUTACOID; CYTOKINE; LEUKOCYTE ANTIGEN; MESSENGER RNA;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIUM ANIMALIS; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; FLOW CYTOMETRY; HISTOLOGY; IMMUNOTHERAPY; LACTOBACILLUS PLANTARUM; LYMPH NODE; MONONUCLEAR CELL; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REGULATORY T LYMPHOCYTE; SPLEEN; T LYMPHOCYTE SUBPOPULATION; TH2 CELL; ANIMAL; C57BL MOUSE; DISEASE EXACERBATION; DISEASE MODEL; DRUG EFFECT; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; LYMPHOCYTE SUBPOPULATION; METABOLISM; MICROBIOLOGY; NERVOUS SYSTEM; PATHOLOGY; PHYSIOLOGY; SPINAL CORD; TH1 CELL; TH17 CELL;

ANIMALS; ANTIGENS, CD; BIFIDOBACTERIUM ANIMALIS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CYTOKINES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LACTOBACILLUS PLANTARUM; LYMPHOCYTE SUBSETS; MICE, INBRED C57BL; MULTIPLE SCLEROSIS; NERVOUS SYSTEM; PROBIOTICS; RNA, MESSENGER; SPINAL CORD; TH1 CELLS; TH17 CELLS;

EID: 85029690146     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2017.08.117     Document Type: Article

References (68)

1. Sospedra, M., Martin, R., Immunology of multiple sclerosis. Annu. Rev. Immunol. 23 (2005), 683–747.
2. Mcfarland, H., Martin, R., Multiple Sclerosis: a complicated picture of autoimmunity. Nat. Immunol. 8 (2007), 913–919.
3. Gold, R., Linington, C., Lassmann, H., Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129 (2006), 1953–1971.
4. Muthian, G., Bright, J.J., Quercetin, a flavonoid phytoestrogen, ameliorates experimental allergic encephalomyelitis by blocking IL-12 signaling though JAK-STAT pathway in T lymphocyte. J. Clin. Immunol. 24:5 (2016), 542–552.
5. Mielcarz, D.W., Kasper, L.H., The gut microbiome in multiple sclerosis. Curr. Treat. Opt. Neurol. 17:4 (2015), 344–347.
6. Mix, E., Meyer-Rienecker, H., Hartung, H., Zettl, U., Animal models of multiple sclerosis – potentials and limitations. Prog. Neurobiol. 92 (2010), 386–404.
7. Markoullis, K., Sargiannidou, I., Gardner, C., Hadjisavas, A., Reynolds, R., Kleopa, k.A., Disruption of oligodendrocyte gap junctions in experimental autoimmune encephalomyelitis. Glia 60 (2012), 1053–1066.
8. McRae, B.L., Kennedy, M.K., Tan, L.J., Dal Canto, M.C., Picha, K.S., Miller, S.D., Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein. J. Neuroimmunol. 38:3 (1992), 229–240.
9. El-behi, M., Rostami, A., Ciric, B., Current views on the roles of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. J. Neuroimmune Pharmacol. 5 (2010), 189–197.
10. Damsker, J.M., Hansen, A.M., Caspi, R.R., Th1 and Th17 cells: adversaries and collaborators. Ann. N. Y. Acad. Sci. 1183 (2010), 211–221.
11. Miller, S., Karpus, W., Experimental autoimmune encephalomyelitis in the mouse. Curr. Protoc. Immunol., 15, 2016, 1 (Chapter unit).
12. + T cells. Curr. Opin. Immunol. 21 (2009), 281–285.
13. Yosef, N., Shalek, A.K., Gaublomme, J.T., Hulin, J., Lee, Y., Awasthi, A., et al. Dynamic regulatory network controlling Th17 cell differentiation. Nature 496:7446 (2013), 461–468.
14. Saraiva, M., O'garra, M., The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10 (2010), 170–181.
15. Dai, H., Ciric, B., Zhang, G., Rostami, A., Interleukin-10 plays a crucial role in suppression of experimental autoimmune encephalomyelitis by bowman-birk inhibitor. J. Neuroimmunol. 245 (2012), 1–7.
16. FAO/WHO, Guidelines for the Evaluation of Probiotics in Food. Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food London., 2002, FAO/WHO, Ontario, Canada.
17. Vaarala, O., Atkinson, M.A., Neu, J., The perfect storm for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 57 (2008), 2555–2562.
18. Ozdermi, O., Any role for probiotics in the therapy or prevention of autoimmune diseases? Up-to-date review. J. Complement. Integr. Med. 10:1 (2013), 1–23.
19. Collins, S., Bercik, P., Relationship between intestinal microbiota and central nervous system in normal gastrointestinal function and disease. J. Gastroenterol. 136 (2009), 2003–2014.
20. Gill, H., Guarner, F., Probiotics and human health: a clinical perspective. Postgrad. Med. J. 80 (2004), 516–526.
21. Tlaskalova-Hogenova, H., Stepankova, R., Hudcovic, T., Tuckova, L., Cukrowska, B., Zadnikova, R.L., et al. Commensal bacteria (normal microflora), mucosal immunity and chonic inflammatory and autoimmune diseases. Immunol. Lett. 93 (2004), 97–108.
22. Baken, A., Ezendam, J., Gremmer, E.R., Klerk, A., Pennings, J.L.A., Matthee, B., et al. Evaluation of immunomodulation by Lactobacillus casei Shirota: immune function, autoimmunity and gene expression. Int. J. Food Microbiol. 112 (2006), 8–18.
23. Maassen, C.B., Claassen, E., Strain dependent effects of probiotic Lactobacilli on EAE autoimmunity. Vaccine 26:17 (2008), 2056–2057.
24. Kobayashi, T., Kato, I., Masanobu, N., Kan, S., Kazumoto, S., Youshiaki, M., Masaharu, O., Oral administration of probiotic bacteria, Lactobacillus casei and Bifidobacterium breve, does not exacerbate neurological symptoms in experimental autoimmune encephalomyelitis. Immunopharmacol. Immunotoxicol. 32 (2010), 116–124.
25. Maassen, C.B., van Holten, J.C., Balk, F., Heijine den Bak-Glashouwer, M.J., Leer, R., Laman, J.D., et al. Orally administered Lactobacillus strains differentially affect direction and efficacy of immune response. Vet. Quart. 20 (1998), 81–83.
26. Dotan, I., Rachmilewitz, D., Probiotics in inflammatory bowel disease: possible mechanisms of action. Curr. Opin. Gastroenterol. 21 (2005), 426–430.
27. Mirlohi, M., Soleimanian-Zad, S., Sheikh-Zeinodin, M., Identification of Lactobacilli from fecal flora of some Iranian infants, Iran. J. Pediatr. 18:4 (2008), 357–363.
28. Mosayebi, G., Haghmored, D., Namaki, S., Ghazavi, A., Ekhtiari, P., Mirshafiey, A., Therapeutic effect of EDTA in experimental model of multiple sclerosis. Immunopharmacol. Immunotoxicol. 32 (2010), 321–326.
29. Toft-Hansen, H., Fuchtbauer, L., Owens, T., Inhibition of reactive astrocytosis in established experimental autoimmune encephalomyelitis favors infiltration by myeloid cells over T cells and enhances severity of disease. Glia 59 (2011), 166–176.
30. Sloka, S., Metz, L.M., Hader, W., Starreveld, Y., Yong, V.W., Reduction of microglial activity in a model of multiple sclerosis by dipyridamole. J. Neuroinflammation, 10, 2013, 89.
31. Horstman, L., Schmid, H., Heinen, A.P., Kurschus, F.C., Dick, H.B., Joachim, S.C., Inflammatory demyelination induces glia alterations and ganglion cell loss in the retina of an experimental autoimmune encephalomyelitis model. J. Neuroinflammation, 10, 2013, 120.
32. Ozdermi, O., Goksu-Erol, A.Y., Probiotics for Autoimmune Diseases: Is There a Benefit?. 2012 www.intechopen.com.
33. Hangi, J., Gandhi, R., Glanz, B., Cook, S., Nejad, P., Ward, D., et al. Increased Archaea species and changes with therapy in gut microbiome of multiple sclerosis subjects (S24.001). Neurology, 82, 2014, S24.00.
34. Ochoa-Reparaz, J., Mielcarz, D., Wang, Y., Begum-Haque, S., Dasgupta, S., Kasper, D.L., Kasper, L.H., A polysaccharide from the human commensal Bacteroides fragilis protects against CNS de-myelinating disease. Mucos. Immunol. 3 (2010), 487–495.
35. Timmerman, H.M., Koning, C.J., Mulder, L., Rombouts, F.M., Beynen, A.C., Monostrain, multistrain and multispecies probiotics–a comparison of functionality and efficacy. Int. J. Food. Microbiol. 96 (2004), 219–233.
36. Timmerman, H.M., Niers, L.E., Ridwan, B.U., Koning, C.J., Mulder, L., Akkermans, L.M., et al. Design of a multispecies probiotic mixture to prevent infectious complications in critically ill patients. Clin. Nutr. 26 (2007), 450–459.
37. Chung, H., Pamp, S.J., Hill, J.A., Surana, N.K., Edelman, S.M., Troy, E.B., et al. Gut immune maturation depends on colonization with a host-specific microbiota. Cell Host Microbe 149 (2012), 1578–1593.
38. Isolauri, E., Sutas, Y., Kankaanpaa, P., Arvilommi, H., Salminen, S., Probiotics: effects on immunity, American. J. Clin. Nutr. 73 (2001), 444s–450s.
39. Ezendam, J., Klerk, A.D., Gremmer, E.R., Loveren, H.V., Effects of bifidobacterium animalis dadministered during lactation on allergic and autoimmune response in rodents. Clin. Exp. Immunol. 154 (2008), 424–431.
40. Kwon, H., Kim, G.C., Kim, Y., Hwang, W., Jash, A., Sahoo, A., et al. Amelioration of experimental autoimmune encephalomyelitis by probiotic mixture is mediated by a shift in T helper cell immune response. Clin. Immunol. 146 (2013), 217–227.
41. Takata, K., Kinoshita, M., Okuno, T., Moriya, M., Kohda, T., Honorat, J.A., et al. The lactic acid bacterium Pediococcus acidilactici suppresses autoimmune encephalomyelitis by inducing IL-10-producing regulatory T-cells. PLoS One, 6, 2011, e27644.
42. Lavasani, S., Dzhambazov, B., Nouri, M., Fak, F., Buske, S., Molin, G., et al. A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10-producing regulatory T-cells. PLoS One, 5(2), 2010, e9009.
43. Nosratabadi, R., Rastin, M., Sankian, M., Haghmorad, D., Mahmoudi, M., Hyperforin-loaded gold nanoparticle alleviates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells and upregulating regulatory T cells. Nanomedicine 12:7 (2016), 1961–1971.
44. Haghmorad, D., Salehipour, Z., Nosratabadi, R., Rastin, M., Kokhaei, P., Mahmoudi, M.B., et al. Medium dose estrogen ameliorates experimental autoimmune encephalomyelitis in ovariectomized mice. J. Immunotoxicol. 13:6 (2016), 885–896.
45. Nosratabadi, R., Rastin, M., Sankian, M., Haghmorad, D., Tabasi, N., Zamani, S., et al. St. John's Wort and its component hyperforin alleviate experimental autoimmune encephalomyelitis though expansion of regulatory T-cells. J. Immunotoxicol. 13 (2016), 364–374.
46. + regulatory cells within central nervous system. J. Immunol. 175 (2005), 3025–3032.
47. Kalka-Moll, W.M., Tzianabos, A.O., Bryant, P.W., Niemeyer, M., Ploegh, H.L., Kasper, D.L., Zwitterionic polysaccharides stimulate T cells by MHC class ІІ-dependent interactions. J. Immunol. 169 (2002), 6149–6153.
48. Mazmanian, S.K., Round, J.L., Kasper, D.L., The love-hate relationship between bacterial polysaccharides and the host immune system. Nat. Rev. Immunol. 6 (2006), 849–858.
49. + regulatory T cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 12204–12209.
50. + regulatory T cells. J. Autoimmun. 40 (2013), 45–57.
51. Miossec, P., Kolls, J.K., Targeting IL-17 and Th17 cells in chonic infammation. Nat. Rev. Drug Discov. 11:10 (2012), 763–776.
52. + T cells subset differentiation and avidity setpoint are dictated by the interplay of cytokine and antigen mediated signals. PLoS One, 9(6), 2014.
53. Di Giacinto, C., Marinaro, M., Sanchez, M., Strober, W., Boirivant, M., Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J. Immunol. 174 (2005), 3237–3246.
54. Calcinaro, F., Dionisi, S., Marinaro, M., Candeloro, P., Bonato Marzotti, V.V.S., et al. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabeto- logia 48 (2005), 1565–1575.
55. Li, M.O., Flavell, R.A., Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. Immunity 28 (2008), 468–476.
56. + regulatory T cells in the control of experimental CNS autoimmune disease. J. Neuroimmunol. 193 (2008), 1–11.
57. Cala, C.M., Moseley, C.E., Steele, C., Dowdy, S.M., Cutter, G.R., Ness, J.M., DeSilva, T.M., T cell cytokine signatures: biomarkers in pediatric multiple sclerosis. J. Neuroimmunol. 297 (2016), 1–8.
58. Anderton, S., Treg and T-effector cells in autoimmune CNS inflammation: a delicate balance easily disturbed. Eur. J. Immunol. 40 (2010), 3321–3324.
59. Rotshenker, S., Wallerian degeneration: the innate-immune response to traumatic nerve injury. J. Neuroinflammation, 8(1), 2011, 109.
60. Haghmorad, D., Mahmoudi, M.B., Salehipour, Z., Jalayer, Z., Momtazi Brojeni, A.A., et al. Hesperidin ameliorates immunological outecome and reduces neuroinflammation in the mouse model of multiple sclerosis. J. Neuroimmunol. 302 (2017), 23–33.
61. Haghmorad, D., Amini, A.A., Mahmoudi, M.B., Rastin, M., Hosseini, M., Mahmoudi, M., Pregnancy level of estrogen attenuates experiimental autoimmune encephalomyelitis in both ovariectomized and pregnant C57BL/6 mice through expansion of Treg and Th2 cells. J. Neuroimmunol. 277 (2014), 85–95.
62. Moore, K.W., De Waal Malefyt, R., Coffman, R.L., O'Garra, A., Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19:1 (2001), 683–765.
63. Sakalidou, M., Leibig, N., Boyle, V., Koulaxouzidis, G., Penna, V., Interleukin-10 and regeneration in an end-to-side nerve repair model of the rat. J. Peripher. Nerv. Syst. 16:4 (2011), 334–340.
64. Collado, M.C., Meriluoto, J., Salminen, S., Development of new probiotics by strain combinations: is it possible to improve the adhesion to intestinal mucus?. J. Dairy Sci. 90 (2007), 2710–2716.
65. Marteau, Ph., Basic aspects and pharmacology of probiotics: an overwiew of pharmacokinetics, mechanisms of action and side-effects. Best. Pract. Res. Clin. Gastoentrol. 17 (2003), 725–740.
66. Hemarajata, P., Versalovic, J., Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Ther. Adv. Gastroentrol. 6 (2013), 39–51.
67. Ochoa-Reparaz, J., Mielcarz, D.W., Begum-Haque, S., Kasper, L.H., Gut, bugs and brain: role of commensal bcteria in the control of central nervous system disease. Ann. Neurol. 69 (2011), 240–247.
68. + Tregs. Mult. Scler. 20 (2014), 285–496.